Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3579]

EMA gives green light to brentuximab vedotin for Hodgkin lymphoma and systemic anaplastic large cell lymphoma

EMA gives green light to brentuximab vedotin for Hodgkin lymphoma and systemic anaplastic large cell lymphoma

FDA grants accelerated approval to carfilzomib injection for multiple myeloma

FDA grants accelerated approval to carfilzomib injection for multiple myeloma

Preclinical genetic data support ongoing clinical trials testing IDO Inhibitors as a treatment for cancer

Preclinical genetic data support ongoing clinical trials testing IDO Inhibitors as a treatment for cancer

Researchers find potential key to new treatment for mantle cell lymphoma

Researchers find potential key to new treatment for mantle cell lymphoma

Immunostimulatory nanoparticles enhance tumour immunotherapy

Immunostimulatory nanoparticles enhance tumour immunotherapy

Researchers discover molecule in immune system that could help treat dangerous skin cancer

Researchers discover molecule in immune system that could help treat dangerous skin cancer

Dabrafenib offers improved progression-free survival for melanoma patients

Dabrafenib offers improved progression-free survival for melanoma patients

$EHA 17: Impressive results in acute lymphocytic leukaemia with the monoclonal antibody blinatumomab in patients with refractory disease$

EHA 17: Impressive results in acute lymphocytic leukaemia with the monoclonal antibody blinatumomab in patients...

Cancer Research Technology and BioInvent enter oncology collaboration

Cancer Research Technology and BioInvent enter oncology collaboration

Kinase targets and anti-targets in cancer poly-pharmacology

Kinase targets and anti-targets in cancer poly-pharmacology

More from ecancer